Press release
Multiplexed Diagnostics Market worth $43.97 billion by 2030, growing at a CAGR of 16.62% - Exclusive Report by 360iResearch
Multiplexed Diagnostics Market | 360iResearch
The Global Multiplexed Diagnostics Market to grow from USD 14.98 billion in 2023 to USD 43.97 billion by 2030, at a CAGR of 16.62%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/multiplexed-diagnostics?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Multiplexed diagnostics allows simultaneous detection and analysis of multiple biomarkers or targets in a single assay or test. Multiplexed diagnostics incorporate multiple detection channels or probes within a single test, enabling the detection of multiple analytes simultaneously. Multiplexed diagnostics can provide a more comprehensive understanding of the disease or condition being analyzed by considering multiple biomarkers or targets, allowing for better accuracy and reliability in diagnostics. Multiplexed diagnostics have become more popular due to growing demand for improved diagnostic technologies, rising incidences of cancer and other infectious diseases, and greater private-public expenditure for genomes and personalized medicine. However, limited multiplexing levels, possible cross-sensitivity between single detection sites, and lack of trained healthcare professionals for handling multiplexed diagnostic equipment impede the utilization of multiplexed diagnostics. In addition, introducing new and advanced multiplexed diagnostic tools and increasing emphasis on R&D activities to generate next-generation sequencing solutions is expected to create tremendous growth opportunities for the multiplexed diagnostics market development.
In the Americas, particularly the United States and Canada, the adoption of multiplexed diagnostics is driven by advanced healthcare infrastructure, a rigorous focus on research and development, and the presence of major diagnostics companies. High prevalence of chronic diseases and significant investment in healthcare technology further accelerated the use of these diagnostics. Consequently, production in this region is highly innovative, with an emphasis on the development of new assays and the integration of digital platforms. The APAC region displays a rapidly growing market for multiplexed diagnostics, mainly due to increasing healthcare expenditure, rising awareness about advanced diagnostic methods, and a growing middle-class population. Countries such as China and India are witnessing increased localization of production as local companies emerge and international players invest in regional manufacturing. Western Europe has a strong foundation similar to the Americas, with well-established healthcare systems favoring early adoption of advanced technologies like multiplexed diagnostics. The production in EMEA is marked by stringent EU regulations, which ensure high-quality standards. Companies operating within EMEA are a mix of established global players and smaller regional companies focusing on specific niche markets.
Market Segmentation & Coverage:
This research report categorizes the Multiplexed Diagnostics Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Method, market is studied across High Density Multiplexed Assays, Low Density Multiplexed Assays, Mid-Density Multiplexed Assays, and Very High Density Multiplexed Assays. The Low Density Multiplexed Assays is projected to witness significant market share during forecast period.
Based on Application, market is studied across Allergic Diseases, Autoimmune Diseases, Cardiology, Infectious Diseases, and Oncology. The Autoimmune Diseases is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Academic Research, Clinical Research, Diagnostic Labs, Hospitals, and Pharma Companies. The Academic Research is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 41.92% in 2023, followed by Europe, Middle East & Africa.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/multiplexed-diagnostics?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Multiplexed Diagnostics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Multiplexed Diagnostics Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Multiplexed Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co., Ltd., Agilent Technologies, Inc., Akoya Biosciences, AusDiagnostics by R-Biopharm, Baxter International Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Cardinal Health, Chembio, ChromaCode, Inc., Danaher Corporation, Delta Diagnostics BV, F. Hoffmann-La Roche AG, Genabio Diagnostics Inc., Hologic, Inc., Illumina, Inc., Leica Biosystems, Medtronic PLC, Merck KGaA, NanoPin Technologies, Novartis AG, PCR Biosystems, QIAGEN N.V., Quansys Biosciences Inc., Seegene, Inc., Siemens Healthineers, Thermo Fisher Scientific, Inc., and West Pharmaceutical Services.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Multiplexed Diagnostics Market, by Method
7. Multiplexed Diagnostics Market, by Application
8. Multiplexed Diagnostics Market, by End-User
9. Americas Multiplexed Diagnostics Market
10. Asia-Pacific Multiplexed Diagnostics Market
11. Europe, Middle East & Africa Multiplexed Diagnostics Market
12. Competitive Landscape
13. Competitive Portfolio
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Multiplexed Diagnostics Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Multiplexed Diagnostics Market?
3. What is the competitive strategic window for opportunities in the Multiplexed Diagnostics Market?
4. What are the technology trends and regulatory frameworks in the Multiplexed Diagnostics Market?
5. What is the market share of the leading vendors in the Multiplexed Diagnostics Market?
6. What modes and strategic moves are considered suitable for entering the Multiplexed Diagnostics Market?
Read More @ https://www.360iresearch.com/library/intelligence/multiplexed-diagnostics?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiplexed Diagnostics Market worth $43.97 billion by 2030, growing at a CAGR of 16.62% - Exclusive Report by 360iResearch here
News-ID: 3411408 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Multiplexed
Multiplexed Diagnostics Market Forecasted to Reach 2019-2027
Transparency Market Research (TMR) has published a new report titled, 'Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global multiplexed diagnostics market was valued at around US$ 8.7 Bn in 2018 and is projected to grow at a CAGR of 17.9% from 2019 to 2027.
Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1719
Overview
•Diagnostic assays are tests used to assess target analytes, quantitatively or qualitatively,…
Valuable Report on Multiplexed Diagnostics Market, 2021-2026
(Portland, United States): A new market research report by Big Market Research on Multiplexed Diagnostics Market reveals that the market is estimated to grow with a substantial growth rate from 2021-2026. This report is a valuable document for major players and the new entrants to scrutinize the market in detail. The insights offered in the report will help the market players to formulate their business strategies and achieve a vital…
Multiplexed Diagnostics Market to Witness Revolutionary Growth
Transparency Market Research (TMR) has published a new report titled, ‘Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global multiplexed diagnostics market was valued at around US$ 8.7 Bn in 2018 and is projected to grow at a CAGR of 17.9% from 2019 to 2027.
Request Brochure for Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1719
Overview
Diagnostic assays are tests used to assess target analytes, quantitatively or qualitatively, in biochemical substances, cells of an organism, or an organic…
RFmondial demonstrates multiplexed DRM at IBC 2019
Hannover, 12.09.2019 – RFmondial demonstrates its advanced multiplexed DRM modulation for the FM band, that allows broadcasters to transmit multiple DRM channels on one physical transmitter.
The newest member of RFmondial’s successful LV-series of DRM modulators and exciters allows the parallel generation and transmission of up to six pure digital DRM channels, or in combined analog and digital „Simulcast” mode, one traditional analog FM channel and up to four DRM channels.
„The…
Multiplexed Diagnostics Market 2017 Specifications and Applications Analysis
Summary:
Latest Research Report “Global Multiplexed Diagnostics Market” Added by Orbis Research which covers Market Overview, Product Specification, Profit, Production, Capacity Utilization, Supply, Manufacturing Process & Cost Structure for Different Regions.
2017 Market Research Report on Multiplexed Diagnostics Industry was a professional and depth research report on Multiplexed Diagnostics industry that you would know the world's major regional market conditions of Multiplexed Diagnostics industry, the main region including North American, Europe and…
Multiplexed Diagnostics Market 2024 - Analysis and Trends
Global Multiplexed Diagnostics Market: Snapshot
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify…
